Clover Health Investments (CLOV) Projected to Post Quarterly Earnings on Tuesday

Clover Health Investments (NASDAQ:CLOV - Get Free Report) is expected to be releasing its earnings data before the market opens on Tuesday, March 11th. Analysts expect Clover Health Investments to post earnings of ($0.07) per share and revenue of $346.92 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.

Clover Health Investments Stock Down 0.8 %

Shares of Clover Health Investments stock traded down $0.03 during mid-day trading on Friday, hitting $3.64. The stock had a trading volume of 6,475,202 shares, compared to its average volume of 6,327,092. The firm has a 50-day moving average of $4.08 and a two-hundred day moving average of $3.61. The firm has a market cap of $1.82 billion, a P/E ratio of -18.20 and a beta of 2.00. Clover Health Investments has a 12-month low of $0.61 and a 12-month high of $4.87.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on CLOV shares. Craig Hallum assumed coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a "buy" rating and a $6.00 target price for the company. Canaccord Genuity Group raised their price objective on Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a research report on Monday.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.